Charles Joel Rosser
Chief Executive Officer at Nonagen Bioscience Corp.
Charles Joel Rosser active positions
| Companies | Position | Start | End |
|---|---|---|---|
Nonagen Bioscience Corp.
 Nonagen Bioscience Corp. BiotechnologyHealth Technology Nonagen Bioscience Corp. is a privately held biotechnology company that focuses on reducing the burden of cancer with innovative diagnostics. The company is currently seeking US Food and Drug Administration approval for Oncuria as an in vitro diagnostic test. The company is based in Los Angeles, CA. The company is committed to bringing best-in-class, noninvasive diagnostics for cancer detection, therapy choice, and disease monitoring to the market. Nonagen's lead diagnostic for bladder cancer, Oncuria®, is available as a laboratory developed test through Diacarta Laboratories. The company is developing diagnostics for bladder, breast, and prostate cancers. Nonagen Bioscience is physician-led and was founded in 2011. The company was founded in 2011 by Charles Joel Rosser, who has been the CEO since then. | Chief Executive Officer | - | - |
| Founder | - | - |
Career history of Charles Joel Rosser
Statistics
International
| United States | 2 |
Operational
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Nonagen Bioscience Corp.
Nonagen Bioscience Corp. BiotechnologyHealth Technology Nonagen Bioscience Corp. is a privately held biotechnology company that focuses on reducing the burden of cancer with innovative diagnostics. The company is currently seeking US Food and Drug Administration approval for Oncuria as an in vitro diagnostic test. The company is based in Los Angeles, CA. The company is committed to bringing best-in-class, noninvasive diagnostics for cancer detection, therapy choice, and disease monitoring to the market. Nonagen's lead diagnostic for bladder cancer, Oncuria®, is available as a laboratory developed test through Diacarta Laboratories. The company is developing diagnostics for bladder, breast, and prostate cancers. Nonagen Bioscience is physician-led and was founded in 2011. The company was founded in 2011 by Charles Joel Rosser, who has been the CEO since then. | Health Technology |
- Stock Market
- Insiders
- Charles Joel Rosser
- Experience
